Oxybutynin and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Oxybutynin (oxybutynin), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Sertraline, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ipf when taking Oxybutynin. It is created by eHealthMe based on reports of 22,833 people who have side effects when taking Oxybutynin from the FDA, and is updated regularly.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.

What is Ipf?

Ipf is found to be associated with 1,741 drugs and 2,278 conditions by eHealthMe. Check the latest studies of Ipf.

On May, 15, 2026

22,833 people reported to have side effects when taking Oxybutynin.
Among them, 37 people (0.16%) have Ipf.

Among these 37 people:

How long have people been on Oxybutynin when they have Ipf? *

What is the gender of people who have Ipf when taking Oxybutynin? *

female: 65.62 %
male: 34.38 %

What is the age of people who have Ipf when taking Oxybutynin? *

What are other drugs people take besides Oxybutynin? *

Sertraline: 11 people, 29.73%
Methotrexate: 8 people, 21.62%
Omeprazole: 8 people, 21.62%
Actemra: 7 people, 18.92%
Premarin: 7 people, 18.92%
Hydrochlorothiazide: 6 people, 16.22%
Valsartan: 6 people, 16.22%
Arava: 6 people, 16.22%
Hydroxychloroquine Sulfate: 6 people, 16.22%
Naproxen: 6 people, 16.22%

What are other side effects people have besides Ipf? *

Dyspnea (difficult or laboured breathing): 15 people, 40.54%
Rashes (redness): 11 people, 29.73%
Fall: 10 people, 27.03%
Oxygen Saturation Decreased: 10 people, 27.03%
Weight Decreased: 9 people, 24.32%
Dyspnea Exertional: 8 people, 21.62%
Joint Pain: 8 people, 21.62%
Back Pain: 8 people, 21.62%
Sinusitis (inflammation of sinus): 7 people, 18.92%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 7 people, 18.92%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 40.54%
High Blood Cholesterol: 14 people, 37.84%
High Blood Pressure: 9 people, 24.32%
Urinary Tract Infection: 5 people, 13.51%
Bladder Disorder: 3 people, 8.11%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 8.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.11%
Bipolar Disorder (mood disorder): 2 people, 5.41%
Joint Pain: 2 people, 5.41%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxybutynin:

Oxybutynin (23,143 reports)

Ipf treatments and more:

Ipf (79,195 reports)

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (1,741 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,278 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin (the active ingredients of Oxybutynin) and Oxybutynin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.